A Study of Administering FOLFIRINOX Before Surgery For Potentially Curable Pancreatic Cancer

NCT03167112 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: Oxaliplatin
DRUG: Irinotecan
DRUG: Leucovorin
DRUG: Fluorouracil

Sponsor

Petr Kavan